NCT02338115View on ClinicalTrials.gov

Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 20, 2016

Study Completion Date

December 20, 2016

Conditions
Breast Cancer
Interventions
DRUG

Paclitaxel 80mg/m2 weekly x 12 weeks

Trial Locations (1)

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT02338115 - Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients | Biotech Hunter | Biotech Hunter